Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Estimation of k and VD of Aminoglycosides

Estimation of k and V_D of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...

Inhibitors of Bacterial Protein Synthesis

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Identifying optimal combination regimens for therapy of Mycobacterium tuberculosis with an algorithmic approach: prospective predictions and validations.

PloS one·2026

Same author

Analyzing Pharmacodynamic Count Data That Rapidly Decrease to Zero.

CPT: pharmacometrics & systems pharmacology·2025

Same author

Pharmacodynamic assessment of apramycin against Mycobacterium abscessus in a hollow fibre infection model.

The Journal of antimicrobial chemotherapy·2025

Same author

Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.

The Journal of antimicrobial chemotherapy·2024

Same author

Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models.

Antimicrobial agents and chemotherapy·2024

Same author

Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against <i>Neisseria gonorrhoeae</i> in a gonococcal hollow-fiber infection model.

Frontiers in pharmacology·2023

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

Optimization of aminoglycoside therapy.

G L Drusano¹, Arnold Louie

¹Ordway Research Institute, 150 New Scotland Ave., Albany, NY 12208, USA. gdrusano@ordwayresearch.org

Antimicrobial Agents and Chemotherapy

|March 16, 2011

Summary

Optimizing aminoglycoside dosing is crucial for treating resistant infections. Daily dosing and personalized pharmacokinetic data improve outcomes while minimizing toxicity risk.

Area of Science:

Pharmacology
Infectious Diseases
Clinical Pharmacy

Background:

Aminoglycosides are increasingly vital for treating multidrug-resistant Gram-negative infections.
Nephrotoxicity is a significant concern associated with aminoglycoside therapy.

Purpose of the Study:

To develop a method for optimizing aminoglycoside dosing to maximize efficacy and minimize toxicity.
To evaluate the impact of different dosing schedules and patient-specific data on treatment outcomes.

Main Methods:

Defined a metric (Δ) representing the difference between likelihoods of good outcome and toxicity.
Developed a method to evaluate Δ for various daily doses and administration schedules.
Incorporated patient-specific pharmacokinetic data for precise dose identification.

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Galleria mellonella as an Antimicrobial Screening Model

Galleria mellonella as an Antimicrobial Screening Model

Published on: October 11, 2024

Related Experiment Videos

Last Updated: Jun 3, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Galleria mellonella as an Antimicrobial Screening Model

Galleria mellonella as an Antimicrobial Screening Model

Published on: October 11, 2024

Main Results:

Every 12-hour dosing is insufficient for infections with MIC > 1 mg/liter, leading to poor outcomes or high toxicity.
Daily administration allows for higher doses with acceptable toxicity, improving treatment success.
Patient-specific pharmacokinetic data rapidly identifies optimal doses for improved outcomes.

Conclusions:

Optimizing aminoglycoside therapy requires understanding exposure-response and exposure-toxicity relationships.
Daily administration is preferred over intermittent dosing.
Shortening therapy duration (≤1 week) aids in optimizing treatment outcomes.